logo-loader
viewMotif Bio PLC

Motif Bio to present at prestigious infectious diseases conference

Graham Lumsden, chief executive of Motif Bio Plc (LON:MTFB), caught up with Proactive's Andrew Scott following the news that three iclaprim abstracts have been accepted for presentation at the upcoming 28th European Congress of Clinical Microbiology and Infectious Diseases in Madrid this April.

ECCMID brings together leading experts in the infectious diseases, infection control and clinical microbiology sectors.

Lumsden says it's an important arena to showcase Motif Bio's iclaprim data.

Quick facts: Motif Bio PLC

Price: 0.65 GBX

AIM:MTFB
Market: AIM
Market Cap: £2.23 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Motif Bio PLC named herein, including the promotion by the Company of Motif Bio PLC in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: AfriTin Mining produces first concentrate from Uis mine

Headlines from the Proactive UK newsroom. AfriTin Mining (LON:ATM) has produced is first tin concentrate from the Uis mine in Namibia. The miner has also signed an offtake deal with a Thai group.  BlueRock Diamonds (LON:BRD) has sold a fifth diamond this year for more than US$50,000....

on 19/8/19

RNS

Second Price Monitoring Extn

1 week, 6 days ago

Price Monitoring Extension

1 week, 6 days ago

Change of Adviser

1 week, 6 days ago

Conditional Placing

2 weeks ago

Second Price Monitoring Extn

2 weeks, 2 days ago

Price Monitoring Extension

2 weeks, 2 days ago

Half-year Report

2 weeks, 2 days ago

2 min read